Published in J Virol on January 01, 2006
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A (2006) 2.69
Transmission and detection of prions in feces. J Infect Dis (2008) 2.20
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol (2013) 2.02
The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog (2011) 1.49
Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. Prion (2009) 1.42
Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog (2008) 1.14
Human prion strain selection in transgenic mice. Ann Neurol (2010) 1.06
Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection. PLoS One (2011) 1.05
The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol (2008) 1.05
A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay. J Gen Virol (2010) 0.90
Prion remains infectious after passage through digestive system of American crows (Corvus brachyrhynchos). PLoS One (2012) 0.87
vCJD and the gut: implications for endoscopy. Gut (2007) 0.86
Identification of I137M and other mutations that modulate incubation periods for two human prion strains. J Virol (2012) 0.86
Ethics in prion disease. Prog Neurobiol (2013) 0.83
Enzymatic activity of a subtilisin homolog, Tk-SP, from Thermococcus kodakarensis in detergents and its ability to degrade the abnormal prion protein. BMC Biotechnol (2013) 0.81
PrP expression level and sensitivity to prion infection. J Virol (2014) 0.81
Detergents modify proteinase K resistance of PrP Sc in different transmissible spongiform encephalopathies (TSEs). Vet Microbiol (2011) 0.81
Proteomic screening for amyloid proteins. PLoS One (2014) 0.80
Prion amplification and hierarchical Bayesian modeling refine detection of prion infection. Sci Rep (2015) 0.78
Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid. PLoS Pathog (2016) 0.76
Kinetics of ozone inactivation of infectious prion protein. Appl Environ Microbiol (2013) 0.76
Exposure of RML scrapie agent to a sodium percarbonate-based product and sodium dodecyl sulfate renders PrPSc protease sensitive but does not eliminate infectivity. BMC Vet Res (2013) 0.76
Ablation of prion protein immunoreactivity by heating in saturated calcium hydroxide. BMC Res Notes (2008) 0.75
Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms. Virulence (2015) 0.75
Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein. Environ Sci Technol (2016) 0.75
Harnessing prions as test agents for the development of broad-range disinfectants. Prion (2012) 0.75
Reversing the amyloid trend: Mechanism of fibril assembly and dissolution of the repeat domain from a human functional amyloid. Isr J Chem (2017) 0.75
Bioassays and Inactivation of Prions. Cold Spring Harb Perspect Biol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Synthetic mammalian prions. Science (2004) 7.35
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
A protease-resistant protein is a structural component of the scrapie prion. Cell (1983) 6.72
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell (1990) 6.17
Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science (1968) 5.76
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12
Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature (1991) 5.04
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet (2004) 4.85
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell (1989) 4.73
Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet (1961) 4.67
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet (2004) 4.59
Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature (1966) 4.29
Does the agent of scrapie replicate without nucleic acid? Nature (1967) 4.14
Linkage of prion protein and scrapie incubation time genes. Cell (1986) 3.69
Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol (1982) 3.68
Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64
Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet (1977) 3.58
A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron (2002) 3.36
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control (1996) 3.07
Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A (2002) 2.91
The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun (1966) 2.83
Inactivation of transmissible degenerative encephalopathy agents: A review. Vet J (2000) 2.71
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell (1994) 2.68
Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci (2001) 2.60
Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol (2004) 2.47
Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry (1980) 2.27
Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A (2005) 2.25
Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol (1991) 2.11
Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med (1985) 2.04
Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A (2003) 2.01
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology (1988) 1.85
Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis. J Infect Dis (1975) 1.79
Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet (1999) 1.74
Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A (1999) 1.73
Novel methods for disinfection of prion-contaminated medical devices. Lancet (2004) 1.68
Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature (1970) 1.66
Infectivity of scrapie prions bound to a stainless steel surface. Mol Med (1999) 1.59
Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sci U S A (1993) 1.52
Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol (2005) 1.43
Antibody to DNA detects scrapie but not normal prion protein. Proc Natl Acad Sci U S A (2004) 1.43
Purified scrapie prions resist inactivation by UV irradiation. J Virol (1987) 1.43
Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. Proc Natl Acad Sci U S A (1978) 1.37
Transmission of prions. Proc Natl Acad Sci U S A (2002) 1.36
Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci U S A (1981) 1.33
Viroids and prions. Proc Natl Acad Sci U S A (1982) 1.33
Branched polyamines cure prion-infected neuroblastoma cells. J Virol (2001) 1.32
Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc Natl Acad Sci U S A (1981) 1.21
Comparative analysis of scrapie agent inactivation methods. J Virol Methods (1993) 1.18
Purified scrapie prions resist inactivation by procedures that hydrolyze, modify, or shear nucleic acids. Virology (1987) 1.16
Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis (2001) 1.10
Pathogenesis of scrapie: agent multiplication in brain at the first and second passage of hamster scrapie in mice. J Gen Virol (1979) 1.07
Inactivation of prions by physical and chemical means. J Hosp Infect (1999) 1.04
The relative susceptibility of sheep, goats and mice to two types of the goat scrapie agent. Res Vet Sci (1966) 1.02
Characterization of thermodynamic diversity between transmissible spongiform encephalopathy agent strains and its theoretical implications. J Biol Chem (2002) 1.00
Advances in veterinary research. Vet Rec (1946) 0.99
Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Vet Rec (1995) 0.98
Resistance of scrapie agent to decontamination. N Engl J Med (1978) 0.98
Reversible chemical modification of the scrapie agent. Science (1981) 0.97
To what extent is strain variation evidence for an independent genome in the agent of the transmissible spongiform encephalopathies? Neurodegeneration (1996) 0.95
Determination of scrapie agent titer from incubation period measurements in hamsters. Adv Exp Med Biol (1981) 0.94
Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996. MMWR Morb Mortal Wkly Rep (1997) 0.92
Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci (1983) 0.91
Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. J Gen Virol (2002) 0.91
Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol Immunol (1991) 0.88
Survival of scrapie agent after exposure to sodium dodecyl sulphate and heat. Vet Microbiol (1999) 0.87
Scrapie agent unlike viruses in size and susceptibility to inactivation by ionizing or ultraviolet radiation. Nature (1985) 0.86
Inactivation of the scrapie agent by pronase. Can J Comp Med (1983) 0.84
Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone. MMWR Morb Mortal Wkly Rep (1985) 0.83
Inactivation of the Creutzfeldt-Jakob disease agent. Ann Neurol (1988) 0.83
Creutzfeldt-Jakob disease after pituitary gonadotrophins. BMJ (1993) 0.81
Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. J Virol (2004) 0.81
Shedding light on proteins, nucleic acids, cells, humans and fish. Mutat Res (2002) 0.79
Prion diseases--an evidence-based protocol for infection control. AORN J (1999) 0.79
Effect of rendering procedures on the scrapie agent. Vet Rec (1998) 0.78
Inactivation of the Creutzfeldt-Jakob disease agent. Ann Neurol (1988) 0.76
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17
Synthetic mammalian prions. Science (2004) 7.35
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med (2012) 6.29
Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A (2007) 5.94
Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA (2008) 5.68
Abnormal brain development in newborns with congenital heart disease. N Engl J Med (2007) 4.55
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr (2010) 4.20
RNA molecules stimulate prion protein conversion. Nature (2003) 4.06
Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab (2011) 3.68
Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64
A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron (2002) 3.36
Prions. Cold Spring Harb Perspect Biol (2011) 3.17
Small-molecule aggregates inhibit amyloid polymerization. Nat Chem Biol (2008) 2.98
Pathway complexity of prion protein assembly into amyloid. J Biol Chem (2002) 2.96
Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A (2002) 2.91
Patterns of brain injury in term neonatal encephalopathy. J Pediatr (2005) 2.86
A checklist for ecological management of landscapes for conservation. Ecol Lett (2007) 2.76
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A (2006) 2.69
Balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries. Circulation (2006) 2.65
A new approach yields high rates of radiographic progression in knee osteoarthritis. J Rheumatol (2008) 2.63
Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr (2005) 2.63
Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med (2004) 2.51
A systems approach to prion disease. Mol Syst Biol (2009) 2.49
Trends in severe brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periventricular leukomalacia. J Pediatr (2004) 2.42
Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A (2009) 2.41
Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol (2006) 2.38
Analysis of proteome dynamics in the mouse brain. Proc Natl Acad Sci U S A (2010) 2.37
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A (2012) 2.36
Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34
Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke (2008) 2.32
Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem (2005) 2.29
Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A (2005) 2.25
Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol (2002) 2.24
Transmission and detection of prions in feces. J Infect Dis (2008) 2.20
Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A (2013) 2.19
Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum (2011) 2.17
High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation (2004) 2.17
Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr (2013) 2.15
Protease-sensitive synthetic prions. PLoS Pathog (2010) 2.14
Diagnosis of human prion disease. Proc Natl Acad Sci U S A (2005) 2.13
MRI findings and sleep apnea in children with Chiari I malformation. Pediatr Neurol (2013) 2.13
Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain (2009) 2.12
Asymptomatic deer excrete infectious prions in faeces. Nature (2009) 2.10
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol (2011) 2.09
Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol (2004) 2.07
Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke (2007) 2.06
Transmission of elk and deer prions to transgenic mice. J Virol (2006) 2.03
Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A (2003) 2.01
Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry (2011) 2.00
Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci U S A (2009) 1.97
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A (2012) 1.97
Lmx1b is required for maintenance of central serotonergic neurons and mice lacking central serotonergic system exhibit normal locomotor activity. J Neurosci (2006) 1.92
Longitudinal trends in the performance of scientific peer reviewers. Ann Emerg Med (2010) 1.90
Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol (2009) 1.83
Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm (2007) 1.82
Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med (2008) 1.82
Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci (2011) 1.79
Prion clearance in bigenic mice. J Gen Virol (2005) 1.79
Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A (2012) 1.77
Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. Am J Psychiatry (2010) 1.76
The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol (2011) 1.76
Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol (2012) 1.75
Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health (2010) 1.75
Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med (2007) 1.73
Regional and central venous oxygen saturation monitoring following pediatric cardiac surgery: concordance and association with clinical variables. Pediatr Crit Care Med (2007) 1.72
Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem (2007) 1.71
Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Sträussler-Scheinker syndrome. J Neurosci (2006) 1.69
Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry (2010) 1.68
Methods for a randomized trial of weight-supported treadmill training versus conventional training for walking during inpatient rehabilitation after incomplete traumatic spinal cord injury. Neurorehabil Neural Repair (2003) 1.68
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Prion-associated dilated cardiomyopathy. Arch Intern Med (2005) 1.66
Conformational transformation and selection of synthetic prion strains. J Mol Biol (2011) 1.66
Copper coordination in the full-length, recombinant prion protein. Biochemistry (2003) 1.66
Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A (2002) 1.65
Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One (2011) 1.65
Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol (2004) 1.63
Measuring prions by bioluminescence imaging. Proc Natl Acad Sci U S A (2009) 1.59
System-level health disparities in California emergency departments: minorities and Medicaid patients are at higher risk of losing their emergency departments. Ann Emerg Med (2011) 1.58